Besides, the expression of glioblastoma stem/progenitor cell markers like CD133 and Oct4 have also been widely investigated in vitro and in vivo concerning their tumor-initiating potential, migratory and proliferative capacity and resistance to chemotherapy [29, 57]. This evidence concerns the gene PROM1 and neoplasm.